Success in value-based care (VBC) is contingent on driving measured improvements in chronic disease management in conditions such as Diabetes.
According to the American Diabetes Association (ADA), the estimated cost of diagnosed diabetes in the United States was $327 billion, and affects more than 37 million Americans.
Research shows that the implementation of comprehensive diabetes management programs that emphasize early identification, lifestyle interventions, and patient education can significantly reduce preventable hospitalizations and long-term healthcare costs related to diabetes complications.
Diagnostic Robotics’ Intelligent Care Journeys empowers health plans and risk-bearing providers with actionable insights, leveraging vast external data to deliver personalized next steps for every patient.